Stock Earnings

Question 1

What are Medexus Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Medexus Pharmaceuticals Inc has a total asset of $171, Net profit of $2

Question 2

What are the key financial ratios for MEDXF?

Accepted Answer

Medexus Pharmaceuticals Inc's Current ratio is 1.43, has a Net margin is 1.85, sales per share of $4.07.

Question 3

How is Medexus Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Medexus Pharmaceuticals Inc data is not available.

Question 4

Is Medexus Pharmaceuticals Inc profitable?

Accepted Answer

yes, according to the latest financial statements, Medexus Pharmaceuticals Inc has a net profit of $2

Question 5

Does Medexus Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, Medexus Pharmaceuticals Inc has liability of 119

Question 6

How many outstanding shares for Medexus Pharmaceuticals Inc?

Accepted Answer

Medexus Pharmaceuticals Inc has a total outstanding shares of 32.25

Breakdown	TTM	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021
Revenue	104	108	113	108	76	79
Revenue Growth (YoY)	0%	-4%	5%	42%	-4%	7%
Cost of Revenue	48	51	53	48	38	37
Gross Profit	55	56	59	60	37	42
Selling, General & Admin	47	43	44	48	44	36
Research & Development	1	1	1	2	5	4
Operating Expenses	49	44	46	51	50	42
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	0	1	0	-5	-3	-31
Income Tax Expense	0	0	0	-6	0	-3
Net Income	0	2	0	1	-2	-28
Net Income Growth	-100%	--	-100%	-150%	-93%	367%
Shares Outstanding (Diluted)	32.28	26.5	22.32	20.52	19.45	15.2
Shares Change (YoY)	32%	19%	9%	6%	28%	6%
EPS (Diluted)	0.01	0.08	0	0.05	-0.14	-1.86
EPS Growth	-82%	-983%	-115.99%	-140%	-92%	333%
Free Cash Flow	13	21	18	-1	-8	-5
Free Cash Flow Per Share	0.4	0.79	0.8	-0.04	-0.41	-0.32
Gross Margin	52.88%	51.85%	52.21%	55.55%	48.68%	53.16%
Operating Margin	4.8%	10.18%	10.61%	7.4%	-15.78%	0%
Profit Margin	0%	1.85%	0%	0.92%	-2.63%	-35.44%
Free Cash Flow Margin	12.5%	19.44%	15.92%	-0.92%	-10.52%	-6.32%
EBITDA	5	11	12	8	-12	0
EBITDA Margin	4.8%	10.18%	10.61%	7.4%	-15.78%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	5	11	12	8	-12	0
EBIT Margin	4.8%	10.18%	10.61%	7.4%	-15.78%	0%
Effective Tax Rate	0%	0%	0%	120%	0%	9.67%

Medexus Pharmaceuticals Inc (MEDXF) Price